Document is current

Article History

Received: 24 November 2025

Accepted: 19 May 2026

First Online: 14 July 2026

Declarations

:

: All authors were involved in the planning and conduct of the work described in this paper. All authors contributed to the writing and granted their final approval of the manuscript before submission. All authors had final responsibility for the decision to submit for publication. All authors read and approved the final version. 

: VH and MS are employed by GSK and hold financial equities in GSK. CPF declares receiving grants from the Swiss Agency for Development and Cooperation and support from the World Health Summit Foundation for attending meetings or travel. T-AE has no financial relationships to disclose. The authors declare no other non-financial relationships and activities or conflicts of interest.

: Data sharing is not applicable as no new data were created or analyzed for this study.

: Not applicable. This study did not use personal data.

: Not applicable. This study did not use personal data.

: Not applicable. This study did not use personal data.

: Not applicable.

: Mosquirix and AS01 are trademarks owned by or licensed to the GSK group of companies.